Skip to main content
. 2023 Jun 24;15(13):3325. doi: 10.3390/cancers15133325

Figure 2.

Figure 2

MRI demonstrating complete radiological response of a TNBC in the right breast after NAST that included Carboplatin and Pembrolizumab in a 50-year-old woman (left: before NAST; right: after NAST). The patient achieved pCR.